Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
62.4% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
6
users have commented on this narrative
49
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
30.9% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
28
users have liked this narrative
5
users have commented on this narrative
77
users have followed this narrative
New
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
19.2% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
10
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
ON Semiconductor
AN
AnalystLowTarget
Consensus Narrative from 30 Analysts
Global Trade Tensions And Regulatory Costs Will Impair Prospects
Key Takeaways Tightening trade barriers, evolving regulations, and tech cycles threaten ON Semiconductor's supply chain stability, cost structure, and ability to sustain growth. Dependence on volatile automotive markets and aggressive investment in new tech elevates risks of revenue swings and margin compression amid rising competition.
View narrative
US$35.39
FV
32.8% overvalued
intrinsic discount
0.051%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
7 days ago
author updated this narrative
JD.com
AN
AnalystLowTarget
Consensus Narrative from 37 Analysts
AI And Supply Chain Investments Will Unlock Retail Opportunities
Key Takeaways Strategic investments and AI tech aim to enhance efficiency, potentially driving growth but risking short-term earnings pressure and margin challenges. Expansion in supermarkets and lower-tier markets promises revenue growth but may limit margins due to competition and price sensitivity.
View narrative
US$28.01
FV
11.9% overvalued
intrinsic discount
6.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
7 days ago
author updated this narrative
Global Payments
AN
AnalystLowTarget
Consensus Narrative from 22 Analysts
Central Bank Digital Currencies Will Erode Legacy Payment Systems
Key Takeaways Central bank digital currencies and blockchain-based platforms are eroding the relevance of traditional payment processors, pressuring Global Payments’ market position and future revenue growth. Intensifying regulatory oversight, fintech competition, and integration risks from acquisitions threaten company margins, operational efficiency, and execution of global expansion strategies.
View narrative
US$64.00
FV
33.7% overvalued
intrinsic discount
-0.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
7 days ago
author updated this narrative
Baidu
AN
AnalystLowTarget
Consensus Narrative from 30 Analysts
Declining Online Marketing Revenue And AI Expenses Will Hurt Outlook
Key Takeaways Declining online marketing revenue and persistent challenges suggest a negative outlook for Baidu's advertising business. Aggressive AI and cloud investments may increase short-term costs, compressing net margins despite future potential.
View narrative
US$71.84
FV
20.8% overvalued
intrinsic discount
2.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
7 days ago
author updated this narrative
Moderna
AN
AnalystLowTarget
Consensus Narrative from 21 Analysts
Dwindling Sales And Delayed Pipelines Will Weaken Biotech Outlook
Key Takeaways Lower demand for COVID and respiratory vaccines, combined with tighter healthcare budgets, is driving revenue declines and limiting pricing power. Revenue volatility and ongoing losses are likely as regulatory hurdles, intense competition, and dependence on few pipeline assets persist.
View narrative
US$20.00
FV
33.6% overvalued
intrinsic discount
-15.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
7 days ago
author updated this narrative
Dow
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Decarbonization Will Squeeze Legacy Chemical Margins In Overcapacity
Key Takeaways Global decarbonization trends and regulatory pressures are undermining demand for Dow's traditional products, compressing margins and threatening long-term profitability. Industry overcapacity and the need for heavy reinvestment are depressing earnings, restricting cash flow, and limiting shareholder returns.
View narrative
US$20.00
FV
6.5% overvalued
intrinsic discount
-1.13%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
7 days ago
author updated this narrative
IQVIA Holdings
AN
AnalystLowTarget
Consensus Narrative from 19 Analysts
Rising Regulatory Burdens And High Debt Will Limit Operations
Key Takeaways Tighter data privacy laws and public scrutiny may restrict growth in analytics platforms and reduce client spending on clinical research services. Rising competition, heavy reliance on debt, and industry consolidation threaten contract wins, financial flexibility, and long-term earnings expansion.
View narrative
US$168.00
FV
5.6% overvalued
intrinsic discount
4.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
7 days ago
author updated this narrative
Fastenal
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Tariff Pressures And Lagging Digital Efforts Will Shape Future Prospects
Key Takeaways Revenue challenges and margin pressures arise from a sluggish marketplace, uncertain macroeconomic conditions, and unabsorbed tariff increases. Incomplete sourcing diversification and elevated inventory levels risk impacting revenue, margins, cash flow, and growth potential.
View narrative
US$32.30
FV
44.8% overvalued
intrinsic discount
7.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
7 days ago
author updated this narrative
Constellation Energy
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
Distributed Energy And Nuclear Setbacks Will Undermine Long Term Stability
Key Takeaways Rapid growth of distributed and renewable energy threatens both customer retention and profitability due to declining demand for grid electricity and increased competition. Regulatory uncertainty and high nuclear operating costs risk eroding earnings stability and may necessitate plant closures or limit long-term investment viability.
View narrative
US$197.27
FV
71.6% overvalued
intrinsic discount
-17.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
7 days ago
author updated this narrative
Value any company in seconds
Popular companies